Drug Database
Back to search

Switzerland· 63145002

Edarbyclor 40 mg/25 mg, Filmtabletten

A azilsartan medoxomil und diurektika product, registered in Switzerland by Takeda Pharma AG and dispensed under Swissmedic category B. The same ATC class is registered in 3 of our 19 countries.

Cat B (Swissmedic)ATC C09DA09

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedEdarbyclor 40 mg/25 mg, FilmtablettenATCC09DA09REGISTER NO.63145002PACKS LISTED0CHECKEDJune 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about EdarbyclorAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Azilsartan medoxomil und diurektika is registered in 3 of 19 countries.

Countries holding a registration under ATC C09DA09 (azilsartan medoxomil und diurektika), each read from that country’s own register.

  • This record: Switzerland
  • 1 of them publish a price we can compare per daily dose
Search azilsartan medoxomil und diurektika products by name

Azilsartan medoxomil und diurektika · ATC C09DA09

3 / 19 countries

  • Canada
  • Netherlands
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
Takeda Pharma AG
Country
Switzerland (CH)
ATC code
C09DA09
ATC class
Azilsartan medoxomil und Diurektika
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

32 interactions on record for azilsartan medoxomil und diurektika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check azilsartan medoxomil und diurektika against other medicinesHow interaction checks work

Azilsartan medoxomil und diurektika · interactions on record

32 records

32 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under C09DA09

Azilsartan medoxomil und diurektika, as other registers publish it.

All azilsartan medoxomil und diurektika products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/706e81df-2d2b-4cb7-aba9-44b43407da9d
GET /v1/drugs/706e81df-2d2b-4cb7-aba9-44b43407da9d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}
API referenceMCP serverPlans

See everything about azilsartan medoxomil und diurektika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console